<?xml version="1.0" encoding="UTF-8"?>
<article article-type="research-article" xml:lang="en" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher">london-journal-of-medical-and-health-research</journal-id>
<journal-title-group>
<journal-title>London Journal of Medical and Health Research</journal-title>
</journal-title-group>
<issn publication-format="print">2515-5784</issn>
<issn publication-format="electronic">2515-5792</issn>
<publisher><publisher-name>JournalsPress</publisher-name></publisher>
<self-uri xlink:href="https://journalspress.com/journal-seo-export/jats/90909.xml" />
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">90909</article-id>
<title-group>
<article-title>Role of Milrinone in Septic Myocardial Depression</article-title>
</title-group>
<volume>23</volume>
<issue>4</issue>
<fpage>27</fpage>
<lpage>31</lpage>
<abstract><p>At present, myocardial depression (MD) in septic shock (SS) is more frequently recognized. In 1984, Parker et al. published 20 patients with SS where 50% of them showed a left ventricular ejection fraction (LVEF) less than 40% 1 . It was not until 2006 that it became more widely accepted that some degree of MD was present in this kind of patients 2 . However, the prevalence has been variable depending on the evaluation method, either through cardiac output (CO), measurement of troponins, B type Natriuretic Peptide or by echocardiography 2-4 . In 2008 Vieillard-Baron et al. studied 67 patients with SS without a history of heart disease with transesophageal echocardiography. They estimated a mean incidence of MD greater than 60%, which manifests itself in the first 48 hours of evolution and recovers between seven and ten days after the onset of SS 5 .</p></abstract>
<self-uri content-type="pdf" xlink:href="http://journalspress.com/LJMHR_Volume23/Role-of-Milrinone-in-Septic-Myocardial-Depression.pdf" />
<self-uri content-type="html" xlink:href="https://journalspress.com/role-of-milrinone-in-septic-myocardial-depression/" />
</article-meta>
</front>
<body>
<sec>
<title>Full Text</title>
<p>At present, myocardial depression (MD) in septic shock (SS) is more frequently recognized. In 1984, Parker et al. published 20 patients with SS where 50% of them showed a left ventricular ejection fraction (LVEF) less than 40% 1 . It was not until 2006 that it became more widely accepted that some degree of MD was present in this kind of patients 2 . However, the prevalence has been variable depending on the evaluation method, either through cardiac output (CO), measurement of troponins, B type Natriuretic Peptide or by echocardiography 2-4 . In 2008 Vieillard-Baron et al. studied 67 patients with SS without a history of heart disease with transesophageal echocardiography. They estimated a mean incidence of MD greater than 60%, which manifests itself in the first 48 hours of evolution and recovers between seven and ten days after the onset of SS 5 .</p>
</sec>
</body>
</article>